HomeSRPT • NASDAQ
Sarepta Therapeutics Inc
$116.46
Jan 27, 3:33:37 PM GMT-5 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$116.46
Day range
$116.45 - $119.44
Year range
$102.16 - $173.25
Market cap
11.12B USD
Avg Volume
749.69K
P/E ratio
95.77
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
467.17M40.79%
Operating expense
128.80M6.16%
Net income
33.61M182.10%
Net profit margin
7.19158.27%
Earnings per share
0.6267.57%
EBITDA
32.00M422.80%
Effective tax rate
1.16%
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
1.20B-30.87%
Total assets
3.60B15.76%
Total liabilities
2.38B1.43%
Total equity
1.22B
Shares outstanding
95.52M
Price to book
9.11
Return on assets
1.58%
Return on capital
2.18%
Net change in cash
(USD)Sep 2024Y/Y change
Net income
33.61M182.10%
Cash from operations
-70.70M38.37%
Cash from investing
-128.82M38.82%
Cash from financing
13.76M-10.70%
Net change in cash
-185.77M40.05%
Free cash flow
-226.28M-48.52%
About
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
Founded
1980
Employees
1,314
Search
Clear search
Close search
Google apps
Main menu